Sign In
Buy LLY
$1,169.86
+53.75 (+4.82%)
At Close: Aug 05, 2026
Is Eli Lilly Stock's Run Too Hot? Here Is How It Can Crash
10:20am, Wednesday, 12'th Nov 2025
Eli Lilly stock (NYSE: LLY) has surged by 21% this month, driven by strong third-quarter earnings and a favorable obesity drug pricing deal with the U.S. government. However, this recent success doesn
IBM's Quantum Push Intensifies, LLY Price Target Hike, ONON Soars 20% on Earnings
10:01am, Wednesday, 12'th Nov 2025
ON Holding (ONON) jumped higher with an earnings beat and guidance raise giving shares a platform to rally. Diane King Hall points to sales doubling in the Asia-Pacific region as a big catalyst.
Cramer's Mad Dash: Eli Lilly
09:54am, Wednesday, 12'th Nov 2025
Jim Cramer breaks down why he's keeping an eye on shares of Eli Lilly.
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock
09:45am, Wednesday, 12'th Nov 2025
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed.
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Nov 2025)
08:20am, Wednesday, 12'th Nov 2025
From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%, before taking a breather this year.
PRIMECAP Management's Strategic Moves: Hess Corp Exit and Chevron Corp Addition
07:01am, Wednesday, 12'th Nov 2025
Analyzing the Third Quarter 2025 13F Filing PRIMECAP Management (Trades, Portfolio) recently submitted its 13F filing for the third quarter of 2025, offering a
This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?
04:22am, Wednesday, 12'th Nov 2025
Eli Lilly released more positive mid-stage clinical trial results for a weight management candidate. The company should dominate this area through the end of the decade, at least, despite the competit
Eli Lilly and Company $LLY Stake Boosted by Accredited Investors Inc.
04:12am, Wednesday, 12'th Nov 2025
Accredited Investors Inc. increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 17.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the
Eli Lilly drops CVS drug plan for workers after Novo obesity deal, Bloomberg News reports
09:34pm, Tuesday, 11'th Nov 2025
Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk , Bloomberg News reported on Tue
Why cutting drug prices is pushing Eli Lilly's stock toward an all-time high
03:20pm, Tuesday, 11'th Nov 2025
Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation.
Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?
11:10am, Tuesday, 11'th Nov 2025
Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and Zepbound fuel investor optimism.
Three Healthcare Buys That Wall Street Loves
10:50am, Tuesday, 11'th Nov 2025
New technologies and an aging population are lifting the healthcare sector. Immunotherapy and anti-obesity drugs are leading the way.
Wall Street is Pounding the Table Over NVDA, RUN, LLY
12:45pm, Monday, 10'th Nov 2025
In addition, according to analysts at UBS, it sees Nvidia guiding fourth quarter revenue to a range of $63 billion to $64 billion.
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease
09:10am, Monday, 10'th Nov 2025
MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to its experimental gene therapy for a rare, inherited disorder that causes s
The futures are trading higher as the new week begins, with most investors and traders relieved that last week has come to a close.
